CTKB
NASDAQ · Life Sciences Tools & Services
Cytek Biosciences Inc
$5.89
+0.06 (+1.03%)
Analyst Consensus
Buy
10
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+857.2% upside
Low Target
$40.67
Average Target
$56.38
High Target
$70.69
Current Price
$5.89
Current
$5.89
$5.89
Target
$56.38
$56.38
$40.67
$56.38 avg
$70.69
Scenario Analysis
Bear Case
$40.67
590.5%
Low target
Base Case
$56.38
+857.2%
Avg target
Bull Case
$70.69
+1,100.2%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$6.34
-7.0% from high
52-Week Low
$3.31
+77.9% from low
Target vs 52W High
$56.38
+790.0% vs high
Next Earnings Report
Nov 11, 2026 · After Market Close
Today
EPS Est: $-0.07
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Life Sciences Tools & Services
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| TMO | Strong Buy | 34 | 79% | $369.21 | -48.6% |
| DHR | Strong Buy | 31 | 84% | $158.11 | -33.0% |
| A | Buy | 30 | 73% | $64.69 | -63.6% |
| IQV | Strong Buy | 26 | 92% | $82.96 | -69.8% |
| WAT | Strong Buy | 28 | 75% | $189.60 | -60.1% |
| MTD | Hold | 19 | 47% | $170.43 | -90.3% |
| ILMN | Hold | 28 | 54% | $169.36 | -21.2% |
| WST | Strong Buy | 21 | 95% | $136.24 | -67.0% |